Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar Psoriasis
Starting soon · Phase 4
Conditions studied: Psoriasis
In brief
To assess whether adding fractional laser to topical corticosteroid improves treatment outcomes in palmoplanter psoriasis compared to topical corticosteroid alone.
Key facts
- Study ID
- NCT07713212
- Run by
- Cairo University
- People needed
- 32
- Starts
- 2026-08-15
- Expected to finish
- 2027-02-15
- Last updated by the study team
- 2026-07-20
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults aged ≥18 years
- Stable psoriasis
- Confirmed cases of palmoplantar psoriasis (with or without psoriasis elsewhere) dermoscopically(Hand _held dermoscopy) and histopathologically if required.
- Willingness to comply with treatment and follow-up
- Written informed consent obtained
You may not qualify if…
- Other palmoplantar dermatoses (eczema, tinea, keratoderma)
- Generlized Pustular psoriasis
- Erythrodermic psoriasis
- Use of:
- Systemic antipsoriatic therapy within 3 months
- Biologic therapy within 12 weeks
- Topical treatment on palms/soles within 2 weeks
- Pregnancy or lactation
- History of photosensitivity disorders
Where it is running
- Cairo University — Cairo, Cairo Governorate, Egypt
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.